ALK and non-small cell lung carcinoma: Nevertheless, a study evaluated whether variant allele frequencies (VAFs) of ALK fusions, assessed by NGS, predicted intratumoral heterogeneity (ITH) and targeted therapy efficacy in NSCLC.